InMed Pharmaceuticals Inc... (INM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.29
-0.22 (-6.27%)
At close: Jan 30, 2025, 11:40 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
Revenue | 4.60M | 4.14M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39.66K | 79.46K | 168.42K | 623.37K | 1.74M | 2.76M | 4.23M | 2.09M | 185.61K | 13.77K | 2.44K |
Cost of Revenue | 3.50M | 2.73M | 545.89K | 197.03K | 183.09K | 93.94K | 92.78K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.76K | 108.89K | 405.58K | 1.82M | 1.42M | 3.19M | 1.20M | 90.02K | 17.16K | 17.02K |
Gross Profit | 1.10M | 1.40M | 543.55K | -197.03K | -183.09K | -93.94K | -92.78K | n/a | n/a | n/a | n/a | n/a | n/a | 39.66K | 70.71K | 59.53K | 217.79K | -80.56K | 1.34M | 1.04M | 892.20K | 95.59K | -3.39K | -14.58K |
Operating Income | n/a | -8.18B | -13.70M | -9.92M | -8.74M | -10.36M | -6.78M | -3.44M | -1.84M | -3.45M | -1.15M | -49.19K | -168.72K | -387.56K | -411.40K | -777.00K | -1.27M | -1.77M | -1.18M | -1.99M | -1.24M | -1.28M | -2.75M | -4.25M |
Interest Income | 527.90K | 492.44K | 96.09K | 16.02K | 125.89K | 330.44K | 69.55K | n/a | n/a | n/a | n/a | 10.45 | 16.71 | -0.39 | -0.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.67M | -7.93M | -18.60M | -10.20M | -8.68M | -10.10M | -6.71M | -3.44M | -1.84M | -3.46M | -1.15M | -46.74K | -189.92K | -461.35K | -515.65K | -1.05M | -1.50M | -1.79M | -1.20M | -2.75M | -1.51M | -1.28M | -2.79M | -2.29M |
Net Income | -7.68M | -7.95M | -18.60M | -10.20M | -8.94M | -10.01M | -6.71M | -3.44M | -1.84M | -3.46M | -1.15M | -46.74K | -189.92K | -325.47K | -334.79K | -1.06M | -922.26K | -1.87M | -1.27M | -2.78M | -1.52M | -1.23M | -2.71M | -4.27M |
Selling & General & Admin | 5.25M | 5.85M | 6.87M | 4.48M | 3.50M | 6.00M | 5.17M | 2.79M | 1.48M | 2.62M | 1.09M | 46.75K | 151.57K | 314.36K | 300.73K | 536.37K | 1.17M | 1.31M | 2.26M | 2.58M | 1.84M | 995.66K | 902.67K | 3.91M |
Research & Development | 3.77M | 3.73M | 7.28M | 5.34M | 5.20M | 4.30M | 1.52M | 573.72K | 292.84K | 759.85K | 57.87K | n/a | 17.03K | n/a | 118.42K | 116.94K | 236.23K | 212.64K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | -308.94K | 185.66K | 120.87K | 161.97K | 94.72K | -0.00 | 75.22K | 67.41K | 75.76K | -900.75 | n/a | n/a | -73.79K | -104.25K | 237.90K | 83.24K | 169.63K | 255.18K | 453.18K | 295.85K | 380.70K | 1.85M | 329.67K |
Operating Expenses | 9.02B | 9.78M | 14.34M | 9.94M | 8.87M | 10.39M | 6.69M | 3.44M | 1.84M | 3.46M | 1.15M | 46.75K | 168.60K | 427.21K | 482.11K | 836.53K | 1.49M | 1.69M | 2.52M | 3.03M | 2.13M | 1.38M | 2.75M | 4.24M |
Interest Expense | n/a | n/a | 96.09K | 360.35K | 18.62K | n/a | n/a | 495.17 | 47.92 | 3.53K | 1.69K | 10.45 | 16.71 | 11.70K | 27.63K | 5.90K | 230.10K | 17.47K | 20.14K | 760.73K | 267.57K | n/a | 32.91K | n/a |
Selling & Marketing Expenses | -5.25B | n/a | n/a | n/a | 474.94K | 706.23K | n/a | 844.27K | 112.64K | 498.44K | 22.65K | n/a | n/a | 27.36K | 63.45K | 97.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.01B | 12.51M | 14.88M | 9.94M | 8.87M | 10.39M | 6.78M | 3.44M | 1.84M | 3.46M | 1.15M | 46.75K | 168.60K | 427.21K | 490.87K | 945.42K | 1.89M | 3.51M | 3.93M | 6.22M | 3.34M | 1.47M | 2.77M | 4.26M |
Income Tax | 7.10K | 13.10K | 4.81M | 360.35K | 18.62K | -262.10K | -69.54K | 495.17 | 47.92 | 3.53K | 1.69K | -2.46K | 21.18K | -73.79K | -104.25K | 791.78K | -347.85K | 99.59K | 99.26K | 816.12K | 277.22K | -50.37K | -40.34K | 15.51K |
Shares Outstanding (Basic) | 7.59M | 2.45M | 560.75K | 270.00K | 210.00K | 210.00K | 172.67K | 108.43K | 72.97K | 55.87K | 41.93K | 40.84K | 40.84K | 17.43K | 4.70K | 3.78K | 3.39K | 2.55K | 1.76K | 1.07K | 13.60K | 3.67K | 3.67K | 3.67K |
Shares Outstanding (Diluted) | 7.59M | 2.45M | 560.83K | 270.00K | 210.00K | 210.00K | 172.67K | 108.43K | 72.97K | 55.87K | 41.93K | 40.84K | 40.84K | 17.43K | 4.70K | 3.78K | 3.41K | 2.64K | 1.76K | 1.07K | 13.60K | 3.67K | 3.67K | 3.67K |
EPS (Basic) | -1.01 | -3.25 | -33.17 | -37.78 | -42.57 | -47.67 | -38.85 | -31.73 | -25.18 | -61.89 | -27.48 | -1.14 | -4.65 | -18.68 | -71.25 | -280.6 | -272.21 | -735.56 | -723.86 | -2.60K | -647.58 | -334.98 | -738.37 | -1.16K |
EPS (Diluted) | -1.01 | -3.25 | -33.17 | -37.78 | -42.57 | -47.67 | -38.85 | -31.73 | -25.18 | -61.89 | -27.48 | -1.14 | -4.65 | -18.68 | -71.25 | -280.6 | -270.3 | -711 | -723.86 | -2.60K | -647.58 | -334.98 | -738.37 | -1.16K |
EBITDA | -7.06M | -10.83M | -17.26M | -9.80M | -8.58M | -10.26M | -6.69M | -3.36M | -1.77M | -3.38M | -1.15M | -46.75K | -168.59K | -252.04K | -341.90K | -608.24K | -1.19M | -973.42K | -920.79K | -1.54M | -946.79K | -900.07K | -906.07K | -2.04M |
Depreciation & Amortization | 604.52K | 596.00K | 511.79K | 197.03K | 183.09K | 94.72K | 89.60K | 75.22K | 67.41K | 75.76K | 40.30 | 2.44K | 133.71 | 135.52K | 69.50K | 168.76K | 83.24K | 169.63K | 252.49K | 426.34K | 295.85K | 380.70K | 1.85M | 2.22M |